Presenting author
Joshua Jordan
3 presentations
Prospective replication of an EEG biomarker for predicting changes in attention in ALTO-203, an H3 inverse agonist
T24. Prospective replication of an EEG biomarker for predicting changes in attention in ALTO-203, an H3 inverse agonist
T58. ALTO-207, a fixed-dose combination of pramipexole and ondansetron, suggests efficacy in treating major depression: Findings from a randomized, double-blind phase 2a trial